Dr. Lee Mun Kam, Bernard
Executive Chairman; Chief Executive Officer
Executive Chairman; Chief Executive Officer
The business, the people and the ownership behind Sing Paincare.
Business overview
Singapore Paincare provides medical services focused on treating and managing chronic and acute pain. Its care ecosystem supports patients through treatment, recovery and ongoing wellness services.
Listed security
Board & management
Executive Chairman; Chief Executive Officer
Executive Chairman; Chief Executive Officer
Executive Director; Chief Operating Officer
Lead Independent Non-Executive Director
Independent Non-Executive Director
Independent Non-Executive Director
Roles listed in Annual Report 2026; current appointments are not independently verified.
Holdings
Direct interest 48,701,500 shares (28.48%); deemed interest –
Substantial shareholders, Register of Substantial ShareholdersDirect interest 29,286,725 shares (17.13%); deemed interest –
Substantial shareholders, Register of Substantial ShareholdersDirect interest 27,853,000 shares (16.29%); deemed interest –
Substantial shareholders, Register of Substantial ShareholdersDirect interest 13,657,450 shares (7.99%); deemed interest –
Substantial shareholders, Register of Substantial ShareholdersTotal interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 14 September 2026 · PDF p. 136
| Registered holder | Interest | Shares / units | Source |
|---|---|---|---|
| LEE MUN KAM, BERNARD | 48,701,500 shares (28.48%) | PDF p. 13614 September 2026 | |
| SIAN CHAY MEDICAL INSTITUTION | 29,286,725 shares (17.13%) | PDF p. 13614 September 2026 | |
| LOH FOO KEONG, JEFFREY | 27,853,000 shares (16.29%) | PDF p. 13614 September 2026 | |
| JITENDRA KUMAR SEN | 13,657,450 shares (7.99%) | PDF p. 13614 September 2026 | |
| CITIBANK NOMINEES SINGAPORE PTE LTD | 5,432,490 shares (3.18%); nominee | PDF p. 13614 September 2026 | |
| LIM CHER KHIANG | 5,355,300 shares (3.13%) | PDF p. 13614 September 2026 | |
| HUANG GUOLIANG, EUGENE | 4,964,730 shares (2.90%) | PDF p. 13614 September 2026 | |
| HC SURGICAL SPECIALISTS LIMITED | 4,041,790 shares (2.36%) | PDF p. 13614 September 2026 | |
| LIM EWE GHEE | 3,787,878 shares (2.22%) | PDF p. 13614 September 2026 | |
| DBS NOMINEES (PRIVATE) LIMITED | 2,279,100 shares (1.33%); nominee | PDF p. 13614 September 2026 | |
| MERLIAOS PTE. LTD. | 2,120,000 shares (1.24%) | PDF p. 13614 September 2026 | |
| MEDINEX LIMITED | 1,972,728 shares (1.15%) | PDF p. 13614 September 2026 | |
| PANG CHEOW JOW | 1,520,100 shares (0.89%) | PDF p. 13614 September 2026 | |
| MAYBANK SECURITIES PTE. LTD. | 1,012,000 shares (0.59%) | PDF p. 13614 September 2026 | |
| LEONG KWOK WAH | 1,000,000 shares (0.58%) | PDF p. 13614 September 2026 | |
| IFAST FINANCIAL PTE. LTD. | 962,500 shares (0.56%) | PDF p. 13614 September 2026 | |
| CHUA MAISIE | 940,000 shares (0.55%) | PDF p. 13614 September 2026 | |
| PHILLIP SECURITIES PTE LTD | 719,300 shares (0.42%) | PDF p. 13614 September 2026 | |
| OCBC SECURITIES PRIVATE LIMITED | 630,100 shares (0.37%) | PDF p. 13614 September 2026 | |
| LEE PENG KHOW | 601,650 shares (0.35%) | PDF p. 13614 September 2026 | |
Group structure
| Company | Market | Ownership interest |
|---|---|---|
| Paincare Center Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 100 | Singapore | |
| Paincare Center Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 100 | 2026: 100; 2025: 100 | |
| Paincare Center Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 100 | 2026: –; 2025: – | |
| Singapore Paincare Center @ Novena Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 100 | Singapore | |
| Singapore Paincare Center @ Novena Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 100 | 2026: 100; 2025: 100 | |
| Singapore Paincare Center @ Novena Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 100 | 2026: –; 2025: – | |
| AE Medical Sengkang Private Limited(1)Main operating subsidiaries; 2026PDF p. 100 | Singapore | |
| AE Medical Sengkang Private Limited(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 100 | 2026: 100; 2025: 100 | |
| AE Medical Sengkang Private Limited(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 100 | 2026: –; 2025: – | |
| HMC Medical Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 100 | Singapore | |
| HMC Medical Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 100 | 2026: 100; 2025: 100 | |
| HMC Medical Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 100 | 2026: –; 2025: – | |
| Lian Clinic Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 100 | Singapore | |
| Lian Clinic Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 100 | 2026: 100; 2025: 100 | |
| Lian Clinic Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 100 | 2026: –; 2025: – | |
| Ready Fit Physiotherapy Private Limited(3)Main operating subsidiaries; 2025 onlyPDF p. 100 | Singapore | |
| Ready Fit Physiotherapy Private Limited(3)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 100 | 2026: –; 2025: 51 | |
| Ready Fit Physiotherapy Private Limited(3)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 100 | 2026: –; 2025: 49 | |
| CS Yoong Anaesthesiology and Pain Services Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 100 | Singapore | |
| CS Yoong Anaesthesiology and Pain Services Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 100 | 2026: 100; 2025: 100 | |
| CS Yoong Anaesthesiology and Pain Services Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 100 | 2026: –; 2025: – | |
| Health Network Asia Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 100 | Singapore | |
| Health Network Asia Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 100 | 2026: 100; 2025: 100 | |
| Health Network Asia Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 100 | 2026: –; 2025: – | |
| Medihealth Clinic Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 100 | Singapore | |
| Medihealth Clinic Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 100 | 2026: 60; 2025: 60 | |
| Medihealth Clinic Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 100 | 2026: 40; 2025: 40 | |
| Kovan Medical and Paincare Clinic Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 100 | Singapore | |
| Kovan Medical and Paincare Clinic Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 100 | 2026: 60; 2025: 60 | |
| Kovan Medical and Paincare Clinic Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 100 | 2026: 40; 2025: 40 | |
| Singapore Paincare TCM Wellness Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 100 | Singapore | |
| Singapore Paincare TCM Wellness Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 100 | 2026: 100; 2025: 100 | |
| Singapore Paincare TCM Wellness Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 100 | 2026: –; 2025: – | |
| Tampines Medical and Paincare Clinic Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 101 | Singapore | |
| Tampines Medical and Paincare Clinic Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 101 | 2026: 100; 2025: 100 | |
| Tampines Medical and Paincare Clinic Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 101 | 2026: –; 2025: – | |
| Centre for Screening and Surgery Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 101 | Singapore | |
| Centre for Screening and Surgery Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 101 | 2026: 51; 2025: 51 | |
| Centre for Screening and Surgery Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 101 | 2026: 49; 2025: 49 | |
| Dermatology & Laser Specialist Clinic Pte. Ltd.(2), (4)Main operating subsidiaries; 2025 onlyPDF p. 101 | Singapore | |
| Dermatology & Laser Specialist Clinic Pte. Ltd.(2), (4)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 101 | 2026: –; 2025: 51 | |
| Dermatology & Laser Specialist Clinic Pte. Ltd.(2), (4)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 101 | 2026: –; 2025: 49 | |
| Hougang Medical and Paincare Clinic Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 101 | Singapore | |
| Hougang Medical and Paincare Clinic Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 101 | 2026: 55; 2025: 55 | |
| Hougang Medical and Paincare Clinic Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 101 | 2026: 45; 2025: 45 | |
| TS Medical Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 101 | Singapore | |
| TS Medical Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 101 | 2026: 51; 2025: – | |
| TS Medical Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 101 | 2026: 49; 2025: – | |
| DR+ Medical & Paincare Telok Blangah Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 101 | Singapore | |
| DR+ Medical & Paincare Telok Blangah Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 101 | 2026: 100; 2025: – | |
| DR+ Medical & Paincare Telok Blangah Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 101 | 2026: 100; 2025: – | |
| East Coast Medical and Paincare Clinic Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 101 | Singapore | |
| East Coast Medical and Paincare Clinic Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 101 | 2026: 55; 2025: 55 | |
| East Coast Medical and Paincare Clinic Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 101 | 2026: 45; 2025: 45 | |
| PTL Spine & Orthopaedics Private Limited(1)Main operating subsidiaries; 2026PDF p. 101 | Singapore | |
| PTL Spine & Orthopaedics Private Limited(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 101 | 2026: 100; 2025: 100 | |
| PTL Spine & Orthopaedics Private Limited(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 101 | 2026: –; 2025: – | |
| Boon Lay Clinic & Surgery Pte. Ltd.(1)Main operating subsidiaries; 2026PDF p. 101 | Singapore | |
| Boon Lay Clinic & Surgery Pte. Ltd.(1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 101 | 2026: 100; 2025: 100 | |
| Boon Lay Clinic & Surgery Pte. Ltd.(1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 101 | 2026: –; 2025: – | |
| Alexandra Medical and Paincare Clinic Pte. Ltd. (1)Main operating subsidiaries; 2026PDF p. 101 | Singapore | |
| Alexandra Medical and Paincare Clinic Pte. Ltd. (1)Main operating subsidiaries; Company ownership; 2026 and 2025PDF p. 101 | 2026: 60; 2025: 60 | |
| Alexandra Medical and Paincare Clinic Pte. Ltd. (1)Main operating subsidiaries; non-controlling interests; 2026 and 2025PDF p. 101 | 2026: 40; 2025: 40 | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| MR. ISAAC PEH LIN SIAH | Financial Controller | PDF p. 17 |
Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| MedBridge Marketing Pte. Ltd. (“MedBridge”)(1) | 547 $’000 | FY2026, aggregate value of all interested person transactions (excluding transactions less than $100,000 and transactions conducted under shareholders’ mandate pursuant to Rule 920); associate of Dr. Lee Mun Kam, Bernard, Executive Chairman and CEO; value under shareholders' mandate: – | PDF p. 70 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Term loan III | Term loan III is repayable over 36 monthly instalments comprising principal and interest. It is supported by personal guarantees provided by the certain Directors of the Company. | Group | PDF p. 117 |
| Term loan I and II | It is supported by deed of guarantee provided by the certain subsidiaries of the Company. | Group | PDF p. 117 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Lee Mun Kam, Bernard | 1,054 S$’000 | FY2026 total remuneration; fee –, base/fixed salary 1,054, variable bonus – | PDF p. 59 |
| Loh Foo Keong, Jeffrey | 1,089 S$’000 | FY2026 total remuneration; fee –, base/fixed salary 1,089, variable bonus – | PDF p. 59 |
| Lim Kah Meng | 10 S$’000 | FY2026 total remuneration; Directors' fee 10 | PDF p. 59 |
| Wong Yee Kong | 40 S$’000 | FY2026 total remuneration; Directors' fee 40 | PDF p. 59 |
| Kenneth Sheah Ban Joo | 20 S$’000 | FY2026 total remuneration; Directors' fee 20 | PDF p. 59 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Total | 106 employees | Group, FY2026 (FY2025: 120; FY2024: 105) | PDF p. 35 |
| Group total headcount | The Group has a total headcount of 91 full-time and 15 part-time employees across our business categories. | Group, FY2026 | PDF p. 34 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Landlord’s termination notice and cessation of TCM business | Subsequent to the financial year end, on 1 September 2026, the Group received a termination notice from Marina Centre Holdings Pte. Ltd. | Group · As at 2026-06-30 | PDF p. 134 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Letter to Shareholders – outlook | Looking ahead, we remain cautiously | Chairman and CEO, FY2026 | PDF p. 9 |
Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.
Corporate information